Leukocytoclastic vasculitis after exposure to COVID-19 vaccine
An Bras Dermatol
.
2022 Jan-Feb;97(1):118-121.
doi: 10.1016/j.abd.2021.09.003.
Epub 2021 Nov 10.
Authors
Matheus Fritzen
1
,
Gabriella Di Giunta Funchal
2
,
Mariana Oliveira Luiz
3
,
Giovanna Steffenello Durigon
4
Affiliations
1
Faculty of Medicine, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil. Electronic address: matheusfritzen2@gmail.com.
2
Department of Dermatopathology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.
3
Department of Dermatology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.
4
Department of Hematology, Universidade Federal de Santa Catarina, Florianópolis, SC, Brazil.
PMID:
34836739
PMCID:
PMC8578015
DOI:
10.1016/j.abd.2021.09.003
No abstract available
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
SARS-CoV-2
Vasculitis, Leukocytoclastic, Cutaneous* / chemically induced
Substances
COVID-19 Vaccines
Supplementary concepts
Erythema elevatum diutinum